Roland Rau

Roland Rau

Auto-generated profile, based on publicly available information

Roland Rau

Max Planck Institute for Demographic Research , Rostock , 18057 , Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2020 in Deutsches Ärzteblatt international
Verified
Journal Article
Closed access
RRRoland Rau
Roland Rau
CSCarl P. Schmertmann
Carl P. Schmertmann
Identifying regions with low life expectancy is important to policy makers, in particular for allocating resources in the health system. Life expectancy estimates for small regions are, however, often unreliable and lead to statistical uncertainties when the underlying populations are relatively small. We combine the most recent German data available (2015–2017) with a Bayesian model that includes several methodological advances. This allows us to estimate male and female life expectancy with good precision for all 402 German districts and to quantify the uncertainty of those estimates. Across districts, life expectancy varies between 75.8 and 81.2 years for men and from 81.8 to 85.7 years for women. The spatial pattern is similar for women and men. Rural districts in eastern Germany and some districts of the Ruhr region have relatively low life expectancy. Districts with relatively high life expectancies cluster in Baden-Wuerttemberg and southern Bavaria. Exploratory analysis shows that average income, population density, and number of physicians per 100 000 inhabitants are not strongly correlated with life expectancy at district level. In contrast, indicators that point to particularly disadvantaged segments of the population (unemployment rate, welfare benefits) are better predictors of life expectancy. We do not find a consistent urban–rural gap in life expectancy. Our results suggest that policies that improve living standards for poorer segment of the population are the most likely to reduce the existing differences in life expectancy.

30 September 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AOAnna Oksuzyan
Anna Oksuzyan
AHAndreas Höhn
Andreas Höhn
JPJacob Krabbe Pedersen
Jacob Krabbe Pedersen
RRRoland Rau
Roland Rau
RLRune Lindahl-Jacobsen
Rune Lindahl-Jacobsen
KCKaare Christensen
Kaare Christensen
Population aging will pose huge challenges for healthcare systems and will require a promotion of positive attitudes towards older people and the encouragement of careers in geriatrics to attract young professionals into the field and to meet the needs of a rapidly growing number of old-aged patients. We describe the current demographic profile of hospital care use in Denmark and make projections for changes in the patient profile up to 2050. The Danish population in 2013 (N = 5.63 million) was followed up for inpatient and emergency admissions recorded in Danish hospitals in 2013 using population-based registers. We combined age- and sex-specific hospital care use in 2013 with official population estimates to forecast the profile of hospital days up to 2050 with respect to age and sex. The total number of hospital days per year is projected to increase by 42% between 2013 and 2050, from 4.66 to 6.72 million days. While small changes are projected for the population aged 0–69, the largest change is projected to occur for the population aged 70+. The 2013 levels were 0.82 and 0.93 million days for men and women aged 70+, respectively. By 2050, these levels are projected to have reached 1.94 and 1.84 million days. While the population aged 70+ accounted for 37.5% of all days in 2013, its contribution is projected to increase to 56.2% by 2050. Our study shows one possible scenario for changes in the hospital days due to population aging by 2050: Assuming no changes in hospital care use over the forecast period, the absolute contribution of individuals aged 70+ to the total hospital days will more than double, and the relative contribution of persons aged 70+ will account for nearly 60% of all hospital days by 2050, being largest among men.

26 May 2021 in Age and Ageing
Verified
Journal Article
Open access
PDF file
MEMarcus Ebeling
Marcus Ebeling
RRRoland Rau
Roland Rau
HMHåkan Malmström
Håkan Malmström
AAAnders Ahlbom
Anders Ahlbom
KMKarin Modig
Karin Modig
Background: Mortality doubles approximately every 6–7 years during adulthood. This exponential increase in death risk with chronological age is the population-level manifestation of ageing, and often referred to as the rate-of-ageing. Objective: We explore whether the onset of severe chronic disease alters the rate-of-ageing. Methods: Using Swedish register data covering the entire population of the birth cohorts 1927–30, we analyse whether being diagnosed with myocardial infarction, diabetes or cancer results in a deviation of the rate-of-ageing from those of the total population. We also quantify the long-term mortality effects of these diseases, using ages with equivalent mortality levels for those with disease and the total population. Results: None of the diseases revealed a sustained effect on the rate-of-ageing. After an initial switch upwards in the level of mortality, the rate-of-ageing returned to the same pace as for the total population. The time it takes for the rate to return depends on the disease. The long-term effects of diabetes and myocardial infarction amount to mortality levels that are equivalent to those aged 5–7 years older in the total population. For cancer, the level of mortality returns to that of the total population. Conclusion: Our results suggest an underlying process of ageing that causes mortality to increase at a set pace, with every year older we become. This process is not affected by disease history. The persistence of the rate-of-ageing motivates a critical discussion of what role disease prevention can play in altering the progression of ageing.

12 January 2017 in Genus
Verified
Journal Article
Open access
PDF file
CBChristina Bohk-Ewald
Christina Bohk-Ewald
RRRoland Rau
Roland Rau
Many mortality forecasting approaches extrapolate past trends. Their predictions of the future development can be quite precise as long as turning points and/or age-shifts of mortality decline are not present. To account even for such mortality dynamics, we propose a model that combines recently developed ideas in a single framework. It (1) uses rates of mortality improvement to model the aging of mortality decline, and it (2) optionally combines the mortality trends of multiple countries to catch anticipated turning points. We use simulation-based Bayesian inference to estimate and run this model that also provides prediction intervals to quantify forecast uncertainty. Validating mortality forecasts for British and Danish women from 1991 to 2011 suggest that our model can forecast regular and irregular mortality developments and that it can perform at least as well as other widely accepted approaches like, for instance, the Lee-Carter model or the UN Bayesian approach. Moreover, prospective mortality forecasts from 2012 to 2050 suggest gradual increases for British and Danish life expectancy at birth.

1 January 2018
Verified
Book
Open access
RRRoland Rau
Roland Rau
CBChristina Bohk-Ewald
Christina Bohk-Ewald
MMMagdalena Muszynska-Spielauer
Magdalena Muszynska-Spielauer
JVJames W. Vaupel
James W. Vaupel
This book visualizes mortality dynamics in the Lexis diagram. While the standard approach of plotting death rates is also covered, the focus in this book is on the depiction of rates of mortality improvement over age and time. This rather novel approach offers a more intuitive understanding of the underlying dynamics, enabling readers to better understand whether period- or cohort-effects were instrumental for the development of mortality in a particular country. Besides maps for single countries, the book includes maps on the dynamics of selected causes of death in the United States, such as cardiovascular diseases or lung cancer. The book also features maps for age-specific contributions to the change in life expectancy, for cancer survival and for seasonality in mortality for selected causes of death in the United States. The book is accompanied by instructions on how to use the freely available R Software to produce these types of surface maps. Readers are encouraged to use the presented tools to visualize other demographic data or any event that can be measured by age and calendar time, allowing them to adapt the methods to their respective research interests. The intended audience is anyone who is interested in visualizing data by age and calendar time; no specialist knowledge is required. This book is open access under a CC BY license.

8 March 2022 in Public Health
Verified
Journal Article
Open access
MEM. Ebeling
M. Ebeling
RRR. Rau
R. Rau
NSN. Sander
N. Sander
EKE. Kibele
E. Kibele
SKS. Klüsener
S. Klüsener
Population aging - which tends to be more pronounced in rural than in urban areas - poses important challenges for facilitating equal opportunities for aging well and 'aging in place.' Unmet health care needs among the older rural population may result in poorer health and higher mortality, but the scientific evidence of a systematic rural mortality disadvantage at older ages is scarce. We argue that systematic urban-rural mortality differences by age may be found if the confounding effect of life expectancy is considered. Nationwide population-based study. We draw on age- and sex-specific data for the population aged 60+ years in NUTS-3 regions in Germany (2016-2018) and LAU-1 regions in England & Wales (2017-2019). To account for the confounding effect of life expectancy, we compare age-specific mortality only across urban and rural regions with similar life expectancy levels. We quantify statistical uncertainty with bootstrapping. The results show a remarkable shift from higher mortality in urban regions to higher mortality in rural regions with increasing age, when controlling for the confounding effect of life expectancy. That is, the urban mortality disadvantage is strongest for the population aged 60-79 years, whereas the pattern shifts toward a rural mortality disadvantage for the population aged 80 years and older. This pattern is present at all levels of life expectancy, for both sexes and in both countries. The shift from urban to rural excess mortality over age suggests that regions may vary in their capability to respond to arising health issues across older ages. This systematic mortality disadvantage is of high public health relevance and should be considered in designing policies to reduce regional mortality disparities.